GlaxoSmithKline, whose diabetes drug Avandia is undergoing a safety review by the FDA, has agreed to pay about $460 million to resolve about 10,000 lawsuits from users of the drug, which can allegedly cause heart attacks and strokes. Continue reading GlaxoSmithKline Settles Majority of Avandia Lawsuits Ahead of FDA Panel Vote GlaxoSmithKline Settles Majority of Avandia Lawsuits Ahead of FDA Panel Vote originally appeared on DailyFinance on Tue, 13 Jul 2010 17:05:00. Filed Under: Company News , Health Care , GlaxoSmithKline Permalink | Tweet this! | Comments